WA HB2145

Prohibits drug manufacturers, distributors, and third-party logistics providers from denying, restricting, or limiting delivery of 340B discounted drugs to covered entities or their contract pharmacies

Bars manufacturers from requiring covered entities to submit claims, utilization, or purchasing data as a condition for 340B drug access, unless federal law mandates such data sharing

Covered entities eligible under 42 U.S.C. Sec. 256b include federally qualified health centers, Ryan White HIV clinics, tribal health centers, critical access hospitals, and safety net hospitals

Covered entities may file civil actions with penalties up to $5,000 per day per violation, with each drug package constituting a separate violation; attorney general may also enforce under consumer protection law

Violations constitute unfair or deceptive trade practices under Washington's Consumer Protection Act (chapter 19.86 RCW)